Medicare readmission penalties climb again as CMS expands payment cuts
Medicare will reduce payments to 2,334 hospitals in fiscal 2027 under the Hospital Readmissions Reduction Program, pushing the penalty rate to 80% of facilities from 78% the year before. The new CMS figures show a steady broadening of financial pressure on hospitals that continue to post higher-than-average readmission rates for selected conditions, even as the program enters its second decade.
The policy took effect Oct. 1 and applies to payment adjustments based on outcomes measured from the summer of 2023 through the summer of 2025. A program built to discourage avoidable returns to the hospital is now reaching into more institutions than it did a year earlier, and the shift is not subtle: 30 additional hospitals are being penalized in 2027 compared with 2026.
One sentence captures the change plainly: more hospitals are paying for readmissions again.
How the penalty formula is being applied
The readmissions reduction policy was created under the Affordable Care Act to pressure hospitals to lower returns after admissions for conditions such as heart attack and pneumonia. CMS uses prior-year Medicare data to determine whether a hospital’s readmission performance exceeds the benchmark, then adjusts Medicare payments accordingly. Penalties can run as high as 3%, but most affected hospitals lose less than 1% of payments.
For fiscal 2027, only 10 hospitals face the maximum 3% reduction, down from 15 in 2026. At the other end of the spectrum, 578 hospitals — about 20% of facilities — will avoid a penalty entirely. Even that small pool represents a decline from the prior year, when 22% of hospitals escaped the program without a reduction.
The fact pattern matters because this is not a one-year fluctuation. It is the second straight year in which more hospitals were penalized than in the year before, suggesting that readmission performance has worsened across enough facilities to move the national distribution of penalties upward.
Why readmissions remain a persistent target
The clinical rationale behind the program is straightforward. Readmissions often reflect gaps in discharge planning, medication reconciliation, follow-up access, or transitions between inpatient and outpatient care. When a patient returns quickly after discharge with decompensated heart failure, recurrent pneumonia, or complications after myocardial infarction, the episode can signal that the original hospitalization did not end with stable handoff to the next setting of care.
Financial penalties were designed to change hospital behavior, and they did. After the program began in 2012, admissions tied to avoidable returns fell substantially, with hospitals investing in discharge education, transition coordination, and post-discharge support. That reduction has translated into billions in Medicare savings each year.
A separate line of research has also found no clear mortality penalty from curbing readmissions, easing one long-running concern that hospitals were simply keeping patients out of the hospital at the expense of survival. The broader policy argument has therefore centered less on whether readmission rates can be moved and more on how fairly the program distributes penalties across hospitals serving different patient populations.
Safety-net concerns still shape the debate
Critics have long argued that the program can hit safety-net hospitals harder because they care for sicker patients with more social risk, less reliable transportation, and more barriers to outpatient follow-up. Those institutions often manage complex discharge pathways for patients with limited resources, language barriers, unstable housing, or multiple chronic illnesses — all factors that make post-discharge recovery harder to sustain.
CMS has taken steps meant to soften those effects, but controversy has not disappeared. Some researchers continue to argue that part of the drop in readmissions may reflect changes in how hospitals classify or track patients rather than pure gains in care quality. In that view, the penalty structure can reward documentation behavior as much as bedside improvement.
The financial stakes remain meaningful even when the average reduction is small. For large hospital systems, a sub-1% cut can still translate into sizable lost revenue across a broad Medicare base, especially when margins are tight and labor costs remain elevated. For smaller facilities, a penalty can carry disproportionate symbolic weight because it marks a failure in a highly visible federal quality program.
Medicare Advantage data now enters the mix
These 2027 penalties are the first to incorporate data that include Medicare Advantage beneficiaries. That change matters because it broadens the universe of outcomes influencing the program and makes the readmission benchmark less dependent on traditional fee-for-service Medicare alone.
The addition of Medicare Advantage data may better reflect the totality of hospital performance, but it also introduces a fresh layer of complexity. Hospitals now face an even wider set of patient pathways, plan rules, and post-discharge arrangements when they try to lower readmissions. A patient’s readmission risk does not respect payer lines, and the same is true for the discharge problems that drive the outcome.
What hospitals are being asked to fix
At the bedside, the levers are familiar: timely discharge planning, medication review, patient teaching, rapid follow-up, and clear communication with outpatient clinicians. The biology of readmission is rarely mysterious. Decompensated heart disease, unresolved infection, poor adherence, and avoidable medication errors all become more likely when discharge occurs before the next steps are secure.
Hospitals that consistently keep readmission rates low tend to make those transitions feel less like a handoff and more like a managed continuation of care. That usually means identifying high-risk patients early, arranging follow-up before discharge, and intervening when social barriers threaten the plan.
For CMS, the broader challenge is whether the program can continue improving outcomes without punishing institutions for the socioeconomic complexity of the patients they serve. For hospitals, the problem is simpler to state and harder to solve: every preventable return now carries a clearer payment consequence.
The 2027 penalty cycle leaves little room for complacency, especially for hospitals that were already operating near the threshold. With 80% of facilities now subject to a payment cut and only 20% escaping unscathed, the program’s reach has widened again — and the next set of outcomes will determine whether this is a temporary uptick or the start of another sustained wave of penalties.